Delivery Order SPE2DB22D3401-SPE2DB24FT3UV

Award Date 7/12/24
Potential Completion Date 8/2/24
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product BENLYSTA 200 MG/ML AUTOINJECTML. The contract, valued at $5,586.06, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product BENLYSTA 200 MG/ML AUTOINJECTML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $5,586.06 and a completion date of July 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product BENLYSTA 200 MG/ML AUTOINJECTML. The contract has a total ceiling value of $2,793.03 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $2,793.03 firm fixed-price delivery order is for the supply of the pharmaceutical product BENLYSTA 200 MG/ML AUTOINJECTML. The contract has an ultimate completion date of December 5, 2024 and was awarded on November 13, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $2,793.03. The award date is June 27, 2024, and the ultimate completion date is July 19, 2024. Amerisourcebergen has a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,379.09 and runs through July 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award was granted to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The $5,586.06 firm fixed price delivery order is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a prescription medication, to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product BENLYSTA 200 MG/ML AUTOINJECTML. The $11,172.12 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), and has a completion date of July 29, 2024. This delivery order contract is not set aside for any specific business category. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. government,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML. The $2,793.03 Firm Fixed Price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has a performance period through November 25, 2024 and was awarded on November 1, 2024. No set-aside requirements were specified for this open competition contract....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the U.S. Defense Department's Medical Supply Chain agency. The $16,758.18 firm fixed-price delivery order contract has a completion date of May 6, 2024 and was awarded on April 15, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT3UV
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product BENLYSTA 200 MG/ML AUTOINJECTML. The $5,586.06 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 2, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This specific contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 10/11/24, 9:20 AM